Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventricular assist devices.

Edith Collard1, Michel J Van Dyck, Luc M Jacquet

  • 1Department of Anaesthesiology, Université Catholique de Louvain, Belgium. collard@anes.ucl.ac.be

Current Opinion in Anaesthesiology
|October 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Life-threatening hypotension in the immediate postoperative period of cataract surgery under topical anesthesia: a report of two cases.

BMC anesthesiology·2023
Same author

Life-threatening hypotension in the immediate postoperative period of cataract surgery under topical anesthesia: a report of two cases.

BMC anesthesiology·2022
Same author

Clonidine or remifentanil for adequate surgical conditions in patients undergoing endoscopic sinus surgery: a randomized study.

PeerJ·2017
Same author

Unplanned intensive care unit admission after general anaesthesia in children: A single centre retrospective analysis.

Anaesthesia, critical care & pain medicine·2016
Same author

Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in an ex vivo model of donation following circulatory death.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2015
Same author

Hypothermic continuous machine perfusion improves metabolic preservation and functional recovery in heart grafts.

Transplant international : official journal of the European Society for Organ Transplantation·2014

Ventricular assist devices (VADs) offer new hope for end-stage heart failure, acting as bridges to transplant or recovery, and even long-term therapy. While complications persist, newer fully implantable VADs show promise for improved outcomes.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Heart Failure Management

Background:

  • Ventricular assist devices (VADs) have seen significant technological advancements and expanded indications.
  • Understanding of myocardial recovery mechanisms following VAD support has improved.

Purpose of the Study:

  • To review recent technological progress in VADs.
  • To discuss new indications for VAD implantation, including permanent therapy.
  • To explore advancements in understanding myocardial recovery with VAD support.

Main Methods:

  • Review of technological developments in pulsatile and continuous flow pumps.
  • Analysis of new clinical indications for VADs.
  • Examination of research on hemodynamic, cellular, molecular, and electrophysiological effects of VADs.

Related Experiment Videos

Main Results:

  • Development of fully implantable axial and centrifugal flow pumps.
  • VADs are increasingly used as permanent treatment for end-stage heart failure.
  • Mechanical assistance improves hemodynamics and cardiac function, suggesting potential for myocardial recovery.
  • High complication rates including device failure, bleeding, thromboembolism, and infection remain a concern.

Conclusions:

  • VADs serve as bridges to transplantation or recovery and are considered long-term myocardial replacement.
  • The optimal VAD for specific indications requires further definition.
  • Fully implantable VADs show promise for efficacy, reliability, and reduced complications.
  • Anesthesiologists must be prepared for VAD patients undergoing surgery.